For many years, chelation therapy has been a controversial approach to cardiovascular conditions. Some people have embraced it enthusiastically, while most physicians have rejected it emphatically.

When determining the types of patients to be recruited for the trial, there was concern that the benefits of chelation might not be easily discerned if the participants were too healthy; patients who ...